https://orcid.org/0000-0002-9961-4576
References
- Tiede A, Collins P, Knoebl P, et al. 2020. International recommendations on the diagnosis and treatment of acquired hemophilia a. Haematologica. 105(7):1791–1801. doi:10.3324/haematol.2019.230771.
- Huth-Kühne A, Baudo F, Collins P, et al. 2009. International recommendations on the diagnosis and treatment of patients with acquired hemophilia a. Haematologica. 94(4):566–575. doi:10.3324/haematol.2008.001743.
- Kruse-Jarres R, Kempton C, Baudo F, et al. Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol. 2017;92(7):695–705. doi:10.1002/ajh.24777.
- National Hemophilia Foundation. Products Licensed in the US. 2021. [cited 2021 1 November]. Available from: https://www.hemophilia.org/healthcare-professionals/guidelines-on-care/products-licensed-in-the-us#5.
- United States Food and Drug Administration. Prescribing Information NovoSeven® RT, Coagulation Factor VIIa (Recombinant). 2014 [ cited 2022]; Available from: https://www.fda.gov/media/70442/download.
- Ellsworth P, Chen SL, Kasthuri RS, et al. Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort. Blood Adv. 2020;4(24):6240–6249. doi:10.1182/bloodadvances.2020002977.
- Batt K, Bullano M, Schultz BG, et al. Evaluating the impact of recombinant porcine factor VIII compared with activated recombinant factor VII on acquired hemophilia A outcomes. Future Rare Dis. 2022;2(2):FRD23.
- Centers for Medicare & Medicaid Services. Historical Impact Files for FY 1994 through present. 2021. Baltimore, MD.
- Centers for Medicare & Medicaid Services. Medicare provider cost report public use files. 2022; Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Cost-Report.
- Centers for Medicare & Medicaid Services. Medicare claims processing manual chapter 3-inpatient hospital billing. 2021. Baltimore, MD.
- Asper F Calculating “Cost”: cost-to-Charge Ratios. cited 2021; Available from: http://resdac.umn.edu/sites/resdac.umn.edu/files/Calculating%20Cost%20-%20Cost-to-Charge%20Ratios%20(Slides).pdf.
- Childers CP, Dworsky JQ, Russell MM, et al. Comparison of cost center–specific vs hospital-wide cost-to-charge ratios for operating room services at various hospital types. JAMA Surg. 2019;154(6):557–558. doi:10.1001/jamasurg.2019.0146.
- Dolan G, Benson G, Bowyer A, et al. Principles of care for acquired hemophilia. Eur J Haematol. 2021;106(6):762–773. doi:10.1111/ejh.13592.
- National Organization for Rare Disorders. Acquired Hemophilia. 2016 [ cited 2021 31 Jun]. Available from: https://rarediseases.org/rare-diseases/acquired-hemophilia/.
- National Organization for Rare Disorders. Hemophilia A. 2015 [ cited 2021 31 Jun]. Available from: https://rarediseases.org/rare-diseases/hemophilia-a/.
- Mustafa M, Moktar AY, Firdaus H, et al. Hemophilia A genetic disorder: diagnosis, treatment and prognosis. ISOR J Dent Med. 2016;15(10):85–89.